Author: Bill Ross | Reading Time: 5 minutes | Published: February 24, 2026 | Updated: March 6, 2026 A pharmaceutical contract development and manufacturing organization wanted to attract more qualified sponsor partnerships, but its sales team struggled with visibility. Many potential clients were searching online for CDMO partners, yet the company was not appearing in the searches buyers actually used. We worked with them to create an SEO and content authority program that improved their presence in organic search. As a result, sales qualified leads (SQLs) increased by 30% during the campaign. A CDMO, or contract development and manufacturing organization, offers drug development, formulation, and manufacturing services to pharmaceutical and biotech companies that do not have these capabilities themselves. The people these companies want to reach—usually VPs or higher at small to mid-size pharma and biotech sponsors—search in very specific ways. Instead of broad queries, they look up the names of dosage forms, regulatory pathways, analytical testing capabilities, and platform technologies. This client had strong technical capabilities but published little content using the language their buyers searched for. Their website described services based on what the facility could do, not on the problems pharma sponsors wanted to solve. This gap between the company’s messaging and buyers’ search habits created an entity association problem we needed to fix. Before creating any content, we mapped out the key entity relationships in this field. Google’s view of CDMOs includes related topics like API manufacturing, drug substance, drug product, fill-finish, analytical development, IND-enabling studies, cGMP manufacturing, and regulatory affairs. These important topics were missing or not mentioned enough on the client’s existing pages.
“Most pharmaceutical manufacturers we work with are technically excellent but strategically invisible online. The problem is not capability. The problem is that their website speaks to internal stakeholders rather than to the procurement decision-makers and scientific leaders at sponsor companies who are doing the actual searching.” — Emulent Strategy Team.
We analyzed the existing service pages using NLP entity extraction and compared the results to top-ranking CDMO content for our target audience’s queries. The gaps we found fit into three main categories. The three entity gap categories we identified: We also analyzed five top CDMOs to see which topics appeared together on their sites. This gave us a map of which topic pairs helped companies rank well for the queries we wanted to target. This analysis helped us set priorities for optimizing pages and creating new content. We also found gaps and topic combinations that competitors had not covered, which became the basis for unique content. With the entity map complete, we structured the program in two focused tracks. First, we updated existing service pages to address critical gaps and depth. Second, we launched new blog content designed to answer the specific questions pharma sponsors ask early in partner evaluation. Our blog strategy focused on decision criteria, not just keywords. We identified the real questions a VP of Technical Operations or a Director of Pharmaceutical Sciences would search for when looking at CDMO partners. These included topics like choosing technology platforms, outsourcing decisions, regulatory risk, and evaluating a manufacturer’s analytical capabilities. Each article was designed to answer a specific question and show the company as a trusted expert. Each content brief we created included clear instructions on which topics to include, how often to mention them, how close they should be to each other, and where they should first appear on the page. This method, explained in our guide to modern entity-based SEO, is different from traditional keyword-focused planning because it focuses on how search engines understand meaning, not just word counts.
“The content brief is where most agencies fall short. They give writers a keyword list and a word count. We give writers an entity map, a semantic context guide, and explicit proximity requirements. That level of specificity is what produces content that ranks and converts.” — Emulent Strategy Team.
Here are the article topics that brought in the most qualified traffic: The measurable outcomes from this program covered organic visibility, lead quality, and pipeline impact. We tracked progress across a defined campaign period and compared performance against the baseline metrics established before the program launched. The 30% increase in SQLs is the main result, but the details show even more. Website traffic almost doubled, and the quality of that traffic improved. Visitors spent more time on blog pages, showing that the articles were genuinely helpful—just as we intended. When content matches the topics and context search engines expect, it also better meets real readers’ needs. The increase from 12 to 41 pages ranking in the top 10 shows the impact of closing entity gaps on existing service pages. Many of these pages had strong technical information but were hard to find because they did not include the related topics that signal authority to search engines. The principles behind this program work for any B2B field where buyers do research before reaching out to vendors. In pharmaceuticals and life sciences, this research phase is especially long and technical. A sponsor company might spend weeks reading about formulation technologies, regulatory requirements, and analytical capabilities before contacting anyone. If your content is missing during this phase, you will not be considered. Entity-based SEO means creating content that matches how search engines connect concepts, organizations, people, and things. Instead of just counting keywords, it checks if the right topics appear together in the right context. This matters because modern search engines use entity graphs and semantic analysis to decide if content truly fits a search query. For B2B companies with complex services, this means content briefs should include not only topics but also which technical terms, regulatory references, process names, and outcome metrics to use together and where. This level of planning helps content rank well for a long time, instead of just briefly.
“Pharmaceutical companies often tell us their audiences are too technical for content marketing to work. What we find is the opposite. Highly technical audiences are the most active searchers. They want detailed, accurate information. When you give it to them and structure it correctly for search, the results are some of the strongest we see across any vertical.” — Emulent Strategy Team.
Here are the parts of the program that contributed most to SQL growth: If your pharmaceutical manufacturing or CDMO company is creating content but not seeing the SQL growth you expect from organic search, the issue is probably not your technical information. More likely, the problem is how the information is structured, which topics are missing, and whether your content answers the specific questions your buyers are researching. Doing an entity gap analysis that compares your site to top competitors for your target queries will reveal these gaps. Our SEO strategies for pharmaceutical and life sciences companies use this structured, entity-focused approach. We also help with broader content strategy and B2B marketing services for companies with complex sales processes. The results from this program are repeatable because they are based on method, not guesswork. When you understand how search engines map entities, and you build content that fills the right gaps in the right way, the pipeline results follow. We work with pharmaceutical manufacturers, CDMOs, and life sciences companies that need their SEO and content programs to produce pipeline results, not just traffic. Our approach starts with entity gap analysis, moves through structured content briefs, and tracks performance at the SQL level because that is what matters to your business. If your pharmaceutical marketing program is not generating the qualified opportunities your sales team needs, contact the Emulent team and let us show you where the gaps are and how to close them. How We Increased Sales Qualified Leads 30% for a Pharma Manufacturer Through SEO and Content Authority
To explain how our approach worked, it helps to first define the main challenge CDMOs face in organic search.
After identifying the visibility challenge, we took a closer look with an entity and keyword gap analysis.
After finding the key gaps, our next step was to build a custom content authority program.
After launching our content authority program, we saw clear results in visibility, leads, and pipeline growth.
Beyond this individual engagement, these results illustrate broader implications for entity and semantic SEO in B2B.
What steps should pharma and biotech companies take next?
How the Emulent Marketing Team can help
